Evidence map›Paper›PMID 38977849›Full record

ArticleThe EMBO journal2024

The tyrosine phosphatases LAR and PTPRδ act as receptors of the nidogen-tetanus toxin complex.

Sunaina Surana, David Villarroel-Campos, Elena R Rhymes, Maria Kalyukina, Chiara Panzi, Sergey S Novoselov, Federico Fabris, Sandy Richter, Marco Pirazzini, Giuseppe Zanotti and 2 more

Abstract read
In one paragraph

Article in The EMBO journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sunaina SuranaDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. s.surana@ucl.ac.uk.ORCID http://orcid.org/0000-0002-7017-3105
David Villarroel-CamposDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.ORCID http://orcid.org/0000-0003-4250-7216
Elena R RhymesDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Maria KalyukinaDepartment of Clinical and Experimental Epilepsy, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Chiara PanziDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.ORCID http://orcid.org/0000-0003-1169-7870
Sergey S NovoselovDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.ORCID http://orcid.org/0000-0002-5491-7522
Federico FabrisDepartment of Biomedical Sciences, University of Padova, Padova, 35131, Italy.
Sandy RichterDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.
Marco PirazziniDepartment of Biomedical Sciences, University of Padova, Padova, 35131, Italy.
Giuseppe ZanottiDepartment of Biomedical Sciences, University of Padova, Padova, 35131, Italy.
James N SleighDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.ORCID http://orcid.org/0000-0002-3782-9045
Giampietro SchiavoDepartment of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. giampietro.schiavo@ucl.ac.uk.ORCID http://orcid.org/0000-0002-4319-8745

Funding

Alzheimer's Society 520Human Frontier Science Program (HFSP) LT000220/2017-LUK Dementia Research Institute (UK DRI) UKDRI-1005UKRI | Medical Research Council (MRC) MR/S006990/1UKRI | Medical Research Council (MRC) MR/X502984/1UKRI | Medical Research Council (MRC) MR/Y010949/1Wellcome TrustWellcome Trust (WT) 107116/Z/15/ZWellcome Trust (WT) 223022/Z/21/Z
6 · The paper itself

Abstract

Tetanus neurotoxin (TeNT) causes spastic paralysis by inhibiting neurotransmission in spinal inhibitory interneurons. TeNT binds to the neuromuscular junction, leading to its internalisation into motor neurons and subsequent transcytosis into interneurons. While the extracellular matrix proteins nidogens are essential for TeNT binding, the molecular composition of its receptor complex remains unclear. Here, we show that the receptor-type protein tyrosine phosphatases LAR and PTPRδ interact with the nidogen-TeNT complex, enabling its neuronal uptake. Binding of LAR and PTPRδ to the toxin complex is mediated by their immunoglobulin and fibronectin III domains, which we harnessed to inhibit TeNT entry into motor neurons and protect mice from TeNT-induced paralysis. This function of LAR is independent of its role in regulating TrkB receptor activity, which augments axonal transport of TeNT. These findings reveal a multi-subunit receptor complex for TeNT and demonstrate a novel trafficking route for extracellular matrix proteins. Our study offers potential new avenues for developing therapeutics to prevent tetanus and dissecting the mechanisms controlling the targeting of physiological ligands to long-distance axonal transport in the nervous system.

Indexed as

Membrane GlycoproteinsMotor NeuronsTetanus ToxinAnimalsAxonal TransportCell Adhesion MoleculesHumansMiceProtein BindingReceptor-Like Protein Tyrosine Phosphatases, Class 2Receptor, trkBCell Adhesion MoleculesMembrane GlycoproteinsnidogenPtprs protein, mouseReceptor-Like Protein Tyrosine Phosphatases, Class 2Receptor, trkBTetanus ToxinLARNeuromuscular JunctionNidogenPTPRδTetanus Toxin

Identifiers

PMID38977849
PMCPMC11329502

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.